These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 177711)

  • 1. Editorial: Hepatoma: a challenging disease.
    Umsawasdi T
    J Med Assoc Thai; 1976 Mar; 59(3):95-9. PubMed ID: 177711
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hepatoma.
    van Dyk JJ
    Proc Mine Med Off Assoc SA; 1975; 55(421):19-20. PubMed ID: 209446
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC; Richards F; Coleman M; Poulin RF; Holland JF; Weinberg V; Perry M
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.
    Keegan-Rogers V; Wu CH; Wu GY
    Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a chemotherapeutic regimen for primary liver cancer in children.
    Senzer NN; Terrell W; Pratt CB
    Cancer Treat Rep; 1978 Sep; 62(9):1403-4. PubMed ID: 210945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local, non-surgical treatment of hepatocellular carcinoma].
    Roche A
    Ann Chir; 1998; 52(1):75-8. PubMed ID: 9752414
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant interferon for hepatocellular carcinoma.
    Okada S; Sato T; Yamamoto S
    Hepatology; 2001 Feb; 33(2):481-2. PubMed ID: 11172357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].
    Burtin P
    Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
    Yamashita T
    J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of N-alkyl-N-nitrosourea on the protein-synthesizing system of liver and hepatoma 22a cells].
    Abakumova OIu; Ugarova TIu; Pilipenko NN; Kutsenko NG; Lerman MI
    Biull Eksp Biol Med; 1973 Oct; 75(10):51-4. PubMed ID: 4360614
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC; Wang L; Wu WZ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
    Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
    Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy for hepatocellular carcinoma].
    Okada S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():645-9. PubMed ID: 11762028
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyprenoic acid in hepatocellular carcinoma.
    Yang CH; Cheng AL
    N Engl J Med; 1996 Nov; 335(19):1460-61; author reply 1461-2. PubMed ID: 8927081
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon for postresection recurrence of hepatocellular carcinoma.
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2002 Dec; 97(12):3200-2. PubMed ID: 12492213
    [No Abstract]   [Full Text] [Related]  

  • 18. Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma.
    Altundag O; Altundag K; Turen S; Gunduz E; Atik MA
    Med Hypotheses; 2006; 66(6):1257. PubMed ID: 16154711
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.